A Study of the Efficacy and Safety of ETC-1002 in Participants With Statin Intolerance

NCT01751984 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: ETC-1002
DRUG: Placebo

Sponsor

Esperion Therapeutics, Inc.